Baseline Donor and Graft Preservation Characteristics and Recipient Characteristics
HCC,, death, HCV, hepatitis C, ischemia, NASH, hepatocellular carcinoma, End-stage Liver Disease
HEPATITIS B, VIRUS, CIRCULATORY ARREST, ISCHEMIA, BRAIN DEATH, NONALCOHOLIC STEATOHEPATITIS, CEREBROVASCULAR ACCIDENT, CDA, COLD
Abbreviations: CDA, combined drug approach; CIT, cold ischemia time; CVA, cerebrovascular accident; DBD, donation after brain death; DCD, donation after circulatory death; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HTK, histidine tryptophan ketoglutarate; ICU, intensive care unit; IGL, Institut Georges Lopez; LOS, length of stay; MELD, Model for End-stage Liver Disease; NASH, nonalcoholic steatohepatitis; UW, University of Wisconsin.Data are presented as number (percentage) of participants unless otherwise indicated.Time from withdrawal of life-sustaining therapy to start of cold aortic perfusion in the donor (applied only to DCD liver transplants).Time from withdrawal of life-sustaining therapy to circulatory arrest (mean arterial pressure <30 mm Hg).Time between the brain death diagnosis and the cold aortic perfusion.Time between the start of aortic cold perfusion and completion of the donor hepatectomy, when the liver was placed in ice water on the back table.Time between the start of cold aortic perfusion and removal of the liver from cold storage before implantation.Possible score range of 4 to 40, with higher scores indicating a higher risk of mortality at 3 months.Time required for graft reperfusion between the liver leaving the ice water and completion of portal vein anastomosis.